PARAISO: BN44715 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS PRASINEZUMAB IN PARTICIPANTS WITH EARLY-STAGE PARKINSON'S DISEASE
Principal Investigator
Kathryn P.L. Moore, MD, MSc
Neurologist
Protocol Number
IRB:
PRO00118941
NCT:
NCT07174310
Phase
Phase III
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment